CITIGROUP INC - CANDEL THERAPEUTICS INC ownership

CANDEL THERAPEUTICS INC's ticker is and the CUSIP is 137404109. A total of 21 filers reported holding CANDEL THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of CANDEL THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$149,451
+23622.4%
118,612
+33596.6%
0.00%
Q4 2022$630
-37.0%
352
+5.1%
0.00%
Q3 2022$1,0000.0%335
-22.1%
0.00%
Q2 2022$1,000
-66.7%
430
-29.5%
0.00%
Q1 2022$3,000
-57.1%
610
-29.6%
0.00%
Q4 2021$7,0008660.00%
Other shareholders
CANDEL THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Northpond Ventures, LLC 1,935,215$1,780,3985.13%
Sands Capital Ventures, LLC 811,737$746,7980.22%
Empirical Asset Management, LLC 10,000$9,2000.01%
Baystate Wealth Management LLC 97,310$89,5250.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132,595$123,3130.00%
FRANKLIN RESOURCES INC 1,125,000$1,046,2500.00%
OneDigital Investment Advisors LLC 25,428$23,3940.00%
WELLS FARGO & COMPANY/MN 108$990.00%
NORTHERN TRUST CORP 19,617$18,0480.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CANDEL THERAPEUTICS INC shareholders